Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ngm Biopharmaceuticals Inc (NGM)

Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NGM Biopharmaceuticals: Q4 Earnings Snapshot

NGM Biopharmaceuticals: Q4 Earnings Snapshot

NGM : 1.5400 (-1.28%)
NGM Biopharmaceuticals: Q3 Earnings Snapshot

NGM Biopharmaceuticals: Q3 Earnings Snapshot

NGM : 1.5400 (-1.28%)
NGM Biopharmaceuticals: Q2 Earnings Snapshot

NGM Biopharmaceuticals: Q2 Earnings Snapshot

NGM : 1.5400 (-1.28%)
NGM Biopharmaceuticals: Q1 Earnings Snapshot

NGM Biopharmaceuticals: Q1 Earnings Snapshot

NGM : 1.5400 (-1.28%)
NGM Biopharmaceuticals: Q4 Earnings Snapshot

NGM Biopharmaceuticals: Q4 Earnings Snapshot

NGM : 1.5400 (-1.28%)
Belharra Therapeutics Debuts With $130 Million in Funding

Belharra Therapeutics, Inc. today emerged from stealth mode with a novel photoaffinity-based chemoproteomics platform capable of identifying non-covalent, small molecule drug candidates for any protein....

NGM : 1.5400 (-1.28%)
NGM Biopharmaceuticals: Q3 Earnings Snapshot

NGM Biopharmaceuticals: Q3 Earnings Snapshot

NGM : 1.5400 (-1.28%)
Bank of America, BP rise; Fox, NGM Biopharmaceuticals fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

GDOT : 12.20 (-2.32%)
GS : 498.43 (-1.07%)
FOXA : 40.21 (-0.67%)
CLR : 74.27 (+0.04%)
BAC : 40.27 (-1.47%)
BP : 32.64 (-0.37%)
NGM : 1.5400 (-1.28%)
CS : 0.8858 (+0.99%)
NGM Bio to Host the Final of Four Virtual R&D Events on June 29, 2022

--NGM621, a monoclonal antibody product candidate engineered to potently inhibit complement C3 for the treatment of patients with geographic atrophy, will...

NGM : 1.5400 (-1.28%)
NGM Bio to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on...

NGM : 1.5400 (-1.28%)

Barchart Exclusives

Snag This Biotech Stock Before November, Here's Why
With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar